Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- CEROW
- Price
- 0.01
- Stock movement up
- +0.00 (45.90%)
- Company name
- CERo Therapeutics Holdings Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Market cap
- -
- Ent value
- 6.43M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return (CAGR)
- -29.92%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
DIVIDENDS
CEROW does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | 5.53 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | - |
| EPS (TTM) | -17.42 |
| FCF per share (TTM) | -9.70 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.16M |
| Gross profit (TTM) | -537.13K |
| Operating income (TTM) | -14.04M |
| Net income (TTM) | -22.03M |
| EPS (TTM) | -17.42 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -46.19% |
| Operating margin (TTM) | -1207.14% |
| Profit margin (TTM) | -1894.48% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.02M |
| Net receivables | 0.00 |
| Total current assets | 2.55M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 3.42M |
| Total assets | 3.91M |
| Accounts payable | 7.08M |
| Short/Current long term debt | 931.02K |
| Total current liabilities | 8.45M |
| Total liabilities | 8.45M |
| Shareholder's equity | -4.54M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -12.27M |
| Capital expenditures (TTM) | 4.00 |
| Free cash flow (TTM) | -12.27M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -563.21% |
| Return on Invested Capital | 609.87% |
| Cash Return on Invested Capital | 339.79% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.01 |
| Daily high | 0.01 |
| Daily low | 0.01 |
| Daily Volume | 89K |
| All-time high | 0.11 |
| 1y analyst estimate | - |
| Beta | 0.29 |
| EPS (TTM) | -17.42 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CEROW | S&P500 | |
| Current price drop from All-time high | -91.72% | -0.89% |
| Highest price drop | -96.19% | -19.00% |
| Date of highest drop | 25 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -87.04% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 287 days | 89 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Small-cap
Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Employees
8
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner